vs
Side-by-side financial comparison of IDACORP INC (IDA) and Medpace Holdings, Inc. (MEDP). Click either name above to swap in a different company.
Medpace Holdings, Inc. is the larger business by last-quarter revenue ($708.5M vs $360.1M, roughly 2.0× IDACORP INC). Medpace Holdings, Inc. runs the higher net margin — 19.1% vs 12.1%, a 7.0% gap on every dollar of revenue. On growth, Medpace Holdings, Inc. posted the faster year-over-year revenue change (32.0% vs -4.2%). Medpace Holdings, Inc. produced more free cash flow last quarter ($188.1M vs $-216.2M). Over the past eight quarters, Medpace Holdings, Inc.'s revenue compounded faster (17.7% CAGR vs -7.2%).
IDACORP, Inc is an electricity holding company, incorporated in Idaho with headquarters in Boise. It comprises Idaho Power Company, IDACORP Financial and Ida-West Energy. It was formed on October 1, 1998.
Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
IDA vs MEDP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $360.1M | $708.5M |
| Net Profit | $43.6M | $135.1M |
| Gross Margin | — | — |
| Operating Margin | 14.9% | 21.6% |
| Net Margin | 12.1% | 19.1% |
| Revenue YoY | -4.2% | 32.0% |
| Net Profit YoY | 15.1% | 15.5% |
| EPS (diluted) | $0.78 | $4.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $360.1M | $708.5M | ||
| Q3 25 | $526.4M | $659.9M | ||
| Q2 25 | $449.3M | $603.3M | ||
| Q1 25 | $411.1M | $558.6M | ||
| Q4 24 | $375.9M | $536.6M | ||
| Q3 24 | $532.5M | $533.3M | ||
| Q2 24 | $442.6M | $528.1M | ||
| Q1 24 | $417.9M | $511.0M |
| Q4 25 | $43.6M | $135.1M | ||
| Q3 25 | $124.4M | $111.1M | ||
| Q2 25 | $95.8M | $90.3M | ||
| Q1 25 | $59.6M | $114.6M | ||
| Q4 24 | $37.9M | $117.0M | ||
| Q3 24 | $113.6M | $96.4M | ||
| Q2 24 | $89.5M | $88.4M | ||
| Q1 24 | $48.2M | $102.6M |
| Q4 25 | 14.9% | 21.6% | ||
| Q3 25 | 27.5% | 21.5% | ||
| Q2 25 | 22.4% | 20.9% | ||
| Q1 25 | 13.4% | 20.3% | ||
| Q4 24 | 11.0% | 23.4% | ||
| Q3 24 | 25.1% | 21.1% | ||
| Q2 24 | 23.3% | 19.9% | ||
| Q1 24 | 11.9% | 20.4% |
| Q4 25 | 12.1% | 19.1% | ||
| Q3 25 | 23.6% | 16.8% | ||
| Q2 25 | 21.3% | 15.0% | ||
| Q1 25 | 14.5% | 20.5% | ||
| Q4 24 | 10.1% | 21.8% | ||
| Q3 24 | 21.3% | 18.1% | ||
| Q2 24 | 20.2% | 16.7% | ||
| Q1 24 | 11.5% | 20.1% |
| Q4 25 | $0.78 | $4.65 | ||
| Q3 25 | $2.26 | $3.86 | ||
| Q2 25 | $1.76 | $3.10 | ||
| Q1 25 | $1.10 | $3.67 | ||
| Q4 24 | $0.72 | $3.67 | ||
| Q3 24 | $2.12 | $3.01 | ||
| Q2 24 | $1.71 | $2.75 | ||
| Q1 24 | $0.95 | $3.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.7M | $497.0M |
| Total DebtLower is stronger | $3.3B | — |
| Stockholders' EquityBook value | $3.6B | $459.1M |
| Total Assets | $10.2B | $2.0B |
| Debt / EquityLower = less leverage | 0.93× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.7M | $497.0M | ||
| Q3 25 | $333.2M | $285.4M | ||
| Q2 25 | $474.5M | $46.3M | ||
| Q1 25 | $634.5M | $441.4M | ||
| Q4 24 | $368.9M | $669.4M | ||
| Q3 24 | $427.9M | $656.9M | ||
| Q2 24 | $169.6M | $510.9M | ||
| Q1 24 | $157.6M | $407.0M |
| Q4 25 | $3.3B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.6B | $459.1M | ||
| Q3 25 | $3.5B | $293.6M | ||
| Q2 25 | $3.4B | $172.4M | ||
| Q1 25 | $3.3B | $593.6M | ||
| Q4 24 | $3.3B | $825.5M | ||
| Q3 24 | $3.3B | $881.4M | ||
| Q2 24 | $3.2B | $763.6M | ||
| Q1 24 | $2.9B | $671.5M |
| Q4 25 | $10.2B | $2.0B | ||
| Q3 25 | $10.1B | $1.8B | ||
| Q2 25 | $9.9B | $1.6B | ||
| Q1 25 | $9.6B | $1.9B | ||
| Q4 24 | $9.2B | $2.1B | ||
| Q3 24 | $9.1B | $2.1B | ||
| Q2 24 | $8.7B | $1.9B | ||
| Q1 24 | $8.3B | $1.8B |
| Q4 25 | 0.93× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.92× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $137.8M | $192.7M |
| Free Cash FlowOCF − Capex | $-216.2M | $188.1M |
| FCF MarginFCF / Revenue | -60.0% | 26.6% |
| Capex IntensityCapex / Revenue | 98.3% | 0.6% |
| Cash ConversionOCF / Net Profit | 3.16× | 1.43× |
| TTM Free Cash FlowTrailing 4 quarters | $-577.5M | $681.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $137.8M | $192.7M | ||
| Q3 25 | $162.8M | $246.2M | ||
| Q2 25 | $176.9M | $148.5M | ||
| Q1 25 | $124.3M | $125.8M | ||
| Q4 24 | $136.4M | $190.7M | ||
| Q3 24 | $201.9M | $149.1M | ||
| Q2 24 | $146.4M | $116.4M | ||
| Q1 24 | $109.7M | $152.7M |
| Q4 25 | $-216.2M | $188.1M | ||
| Q3 25 | $-127.9M | $235.5M | ||
| Q2 25 | $-156.4M | $142.4M | ||
| Q1 25 | $-77.0M | $115.8M | ||
| Q4 24 | $-48.9M | $183.0M | ||
| Q3 24 | $-16.1M | $138.5M | ||
| Q2 24 | $-199.6M | $103.5M | ||
| Q1 24 | $-150.3M | $147.2M |
| Q4 25 | -60.0% | 26.6% | ||
| Q3 25 | -24.3% | 35.7% | ||
| Q2 25 | -34.8% | 23.6% | ||
| Q1 25 | -18.7% | 20.7% | ||
| Q4 24 | -13.0% | 34.1% | ||
| Q3 24 | -3.0% | 26.0% | ||
| Q2 24 | -45.1% | 19.6% | ||
| Q1 24 | -36.0% | 28.8% |
| Q4 25 | 98.3% | 0.6% | ||
| Q3 25 | 55.2% | 1.6% | ||
| Q2 25 | 74.2% | 1.0% | ||
| Q1 25 | 49.0% | 1.8% | ||
| Q4 24 | 49.3% | 1.4% | ||
| Q3 24 | 41.0% | 2.0% | ||
| Q2 24 | 78.2% | 2.4% | ||
| Q1 24 | 62.2% | 1.1% |
| Q4 25 | 3.16× | 1.43× | ||
| Q3 25 | 1.31× | 2.22× | ||
| Q2 25 | 1.85× | 1.65× | ||
| Q1 25 | 2.08× | 1.10× | ||
| Q4 24 | 3.60× | 1.63× | ||
| Q3 24 | 1.78× | 1.55× | ||
| Q2 24 | 1.63× | 1.32× | ||
| Q1 24 | 2.28× | 1.49× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDA
| Retailrevenues | $323.0M | 90% |
| Transmissionserviceswheeling | $18.6M | 5% |
| Energyefficiencyprogramrevenues | $11.7M | 3% |
| Wholesaleenergysales | $10.5M | 3% |
| Otherrevenues | $9.5M | 3% |
MEDP
| Metabolic | $249.8M | 35% |
| Oncology | $195.9M | 28% |
| Other | $88.3M | 12% |
| Central Nervous System | $73.2M | 10% |
| Cardiology | $63.0M | 9% |
| Antiviral And Anti Infective | $38.3M | 5% |
| Related Party | $10.3M | 1% |
